Swedish epidemiological study documents 40% increase in psychiatric medications among PhD candidates during their programs.

The 5-HT2A receptor in the brain reduces incoming visual information, allowing more space for internal thought processes.

ETH Zurich researchers discover the potential of antidepressants in treating aggressive brain tumors like glioblastoma.

Novo Nordisk, the manufacturer behind Ozempic and Wegovy, has another weight loss medication in the works with some ...

Behind the overhaul of Alberta’s larger addictions-treatment system is Marshall Smith.

The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health ...

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...